DBVT - DBV Technologies
DBV Technologies Logo

DBVT - DBV Technologies

https://www.dbv-technologies.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, France.

52W High
$12.78
52W Low
$2.20
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.48
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.07
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
65.99
P/B (<3 favorable)
2.85
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
5.30%
Shares Outstanding
27,362,100
Float
79,423,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
3,800,000
Gross Profit (TTM)
3,800,000
EPS (TTM)
-5.60
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-28.06%
ROE (TTM) (>15% strong)
-1.48%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.26
Momentum
Bearish momentum
Value
-0.0244
Previous
-0.0778
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025